Bio & Health Tech AI: Risks, Returns, and Roadmaps

Carmen Castaneda Sceppa MD, PhD, FGSA

Dean of Bouvé College of Health Sciences

Dr. Sceppa is a clinician, researcher, educator, mentor, and leader. Her work centers around advancing and prolonging health for all. Her research seeks to understand the role of lifestyle interventions on advancing overall health and quality of life. She examines health and wellness in settings that promote physical activity among underserved and vulnerable populations, specifically, older adults and the elderly, particularly Hispanics and African Americans. Dr. Sceppa’s research has provided evidence-based information to transform the way we think about healthy lifestyle from personal choice to preventive medicine.

‍

Andrea De Souza, Qubit Pharmaceuticals, Chief Corporate Development Officer

The digital era of biology and healthcare has been poised to redefine healthcare through the transformative use of data, AI and now, quantum.  Sustained innovation with data and AI has and will continue to drive insights and impact. With this short talk, we will weave in quantum AI as an additional catalyst for insights, innovation and impact as we highlight the risks, rewards and challenges required to ensure equitable and impactful advancements.

‍

Andrea de Souza is the Chief Corporate Development Officer for Qubit Pharmaceuticals, an early-stage molecule discovery company focused on accelerating the use of AI, physics-based and Quantum AI at scale.  As a tenured executive her career focus has included leadership roles with transformative impact at Amgen, the Broad Institute of Harvard and MIT, NVIDIA and Eli Lilly.  She currently serves as an advisor to an AI fund and advises companies working at the intersection of life sciences, technology and new market development.

Usama Fayyad

Senior Vice Provost for AI and Data Strategy and Senior Advisor to the President

Inaugural Executive Director, The Institute for Experiential AI

Northeastern University

Usama Fayyad is the senior vice provost for AI and data strategy, senior advisor to the president, and a professor of the practice in the Khoury College of Computer Sciences. He continues to serve as chairman of Open Insights, a company he founded as a technology and consulting firm in 2008 to enable enterprises to extract greater value from their data assets. He co-founded OODA Health, Inc., and from 2017 to 2019 served as the company’s chief technology officer. Between 2013 and 2016 he was global chief data officer and group managing director at Barclays Bank in London.  

He has published more than 100 technical articles on data science, holds over 20 patents, and is a fellow of both the Association for the Advancement of Artificial Intelligence and the Association for Computing Machinery. He has also edited two influential books on data science and served as founding editor-in-chief on two key journals. He currently serves on the board advisory committee to Nationwide Building Society in the U.K. and on the advisory board of the WEF Global Center for Cybersecurity. Fayyad is an active angel investor/advisor in many early-stage tech startups across the U.S., Europe, and the Middle East.

‍